Retrophin Inc. (NASDAQ:RTRX) said it has entered into a license agreement with Mission Pharmacal Co. for U.S. marketing rights to recurring-kidney-stone treatment Thiola, while boosting its revenue outlook. Retrophin Inc. (NASDAQ:RTRX) stock opened today at $16.78 and is currently trading at $14.99. The stock showed a positive weekly performance of 0.31%.
NewLink Genetics Corporation (NASDAQ:NLNK) announced data from a Phase 2 clinical study of its dorgenmeltucel-L HyperAcute immunotherapy in combination with pegylated interferon-alpha 2b in patients with advanced metastatic, progressive, refractory or recurrent melanoma. The study will be featured in the upcoming edition of The Ochsner Journal, Volume 14, Number 2, summer 2014, Academic Division of Ochsner Clinic Foundation. NewLink Genetics Corp (NASDAQ:NLNK) stock opened at $22.42, in current trading session and currently is at $20.99, by gaining 6.06%. The 52 week range of $15.61 – $53.48. Company’s market capitalization is 585.08 million.
Oncothyreon Inc. and Celldex Therapeutics Inc. (NASDAQ:CLDX) announced that they have agreed to collaborate on a combined clinical trial of ONT-10 and varlilumab. ONT-10 is a therapeutic vaccine targeting the tumor-associated antigen MUC1. Varlilumab is a fully human monoclonal antibody that targets CD27, a critical molecule in the activation pathway of lymphocytes. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock is currently trading at $14.63. The EPS of the stock is -1.12. Company’s market capitalization is 1.31 billion.
Analysts at Cantor Fitzgerald started coverage on shares of Array BioPharma (NASDAQ:ARRY) in a research report issued to clients and investors on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock. Array Biopharma Inc. (NASDAQ:ARRY) stock opened the session at $4.36, and now is at $4.31. The 52 week range of the Array Biopharma Inc. (NASDAQ:ARRY) stock remained $3.39 – $7.10 and the day range was $4.26 – $4.38.
The Rangers registered a 1-0 at Madison Square Garden Co (NASDAQ:MSG) to complete a 4-2 series win over the Canadiens. The Madison Square Garden Co (NASDAQ:MSG) stock opened today at $55.90 and is currently trading at $55.35. The stock showed a positive weekly performance of 3.69%.